Blood Eosinophil Count is the Dominant Clinical Marker for type 2 Inflammatory Severity in CRSwNP. Wu PW, Huang CC, Chang PH, Lee TJ, et al. Laryngoscope 2025;135:1326-1334.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu PW, Huang CC, Chang PH, Lee TJ, et al. Blood Eosinophil Count is the Dominant Clinical Marker for type 2 Inflammatory Severity in CRSwNP. Laryngoscope 2025;135:1326-1334.
PMID: 39601113